Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze URGN stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate URGN investment potential.

What is URGN stock price today?

Get real-time URGN stock price, historical data, and price charts on Financhill. Track URGN performance with our advanced analysis tools.

Is URGN a good investment?

Evaluate URGN investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy URGN stock?

To buy URGN stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of URGN?

View detailed market capitalization data and company valuation metrics for URGN on our comprehensive analysis page.

What is the P/E ratio of URGN?

Use our fundamental analysis tools to view URGN P/E ratio and compare valuation metrics with industry peers.

What are URGN earnings?

View URGN earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

UroGen Pharma Ltd. 10K Form

Sell

URGN
UroGen Pharma Ltd.

Last Price:

$23.46

Seasonality Move:

-2.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-14	10Q	URGN/UroGen Pharma Ltd. Quarterly
2023-08-10	10Q	URGN/UroGen Pharma Ltd. Quarterly
2023-05-11	10Q	URGN/UroGen Pharma Ltd. Quarterly
2022-11-10	10Q	URGN/UroGen Pharma Ltd. Quarterly
2022-08-11	10Q	URGN/UroGen Pharma Ltd. Quarterly
2022-05-10	10Q	URGN/UroGen Pharma Ltd. Quarterly

Receive URGN News And Ratings

See the #1 stock for the next 7 days that we like better than URGN

URGN Financial Statistics

Sales & Book Value

Annual Sales:	$90.4M
Cash Flow:	$-47.6M
Price / Cash Flow:	0
Annual Sales:	$-2.47
Price / Book:	16.41

Profitability

EPS (TTM):	-3.46210
Net Income (TTM):	$-164.6M
Gross Margin:	$81.5M
Return on Equity:	0%
Return on Assets:	-66.98%

UroGen Pharma Ltd. Earnings Forecast

Key UroGen Pharma Ltd. Financial Ratios

The Gross Profit Margin over the past 10 years for URGN is 90.18%.
The Selling, General & Administrative Expenses for URGN have been equal to 134.02% of Gross Profit Margin.
The Research & Development expenses have been 63.21% of Revenue.
The Net Earning history of URGN is -140.35% of Total Revenues.
Per Share Earnings over the last 10 years have been positive in 5 years.

UroGen Pharma Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	URGN
CUSIP:	M96088
Website:	urogen.com

Debt

Debt-to-Equity Ratio:	-1.13
Current Ratio:	3.99
Quick Ratio:	3.51

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

URGN Technical Analysis vs Fundamental Analysis